AuroMedics Pharma LLC, a US subsidiary of Aurobindo Pharma Ltd,has initiated voluntary recall of two lots each of two injections from the US market followingcustomer complaintsabout presence of particles in the vial.
The fresh recall follows a recent withdrawal of over 1.5 million injections by the company due to "Lack of Assurance of Sterility."
"AuroMedics Pharma LLC is notifying its distributors and customers by recall letters and is arranging for replacement etc. of all recalled product."
Disclaimer: No Business Standard Journalist was involved in creation of this content